Important announcements in the Hong Kong stock market today:
1) Company News
$FIH (02038.HK)$ In the first quarter, revenue and other operating income was approximately 1.017 billion USD, a year-on-year increase of 1.91%; net income was 1.072 million USD, turning a profit from a loss year-on-year.
The announcement states that financial performance in the first half of the year is expected to improve compared to the same period last year, primarily due to increased sales in the automotive electronics and robot sectors.
$SWIRE PACIFIC A (00019.HK)$ / $SWIRE PACIFIC B (00087.HK)$ Planning to spin off TCPCL and list independently on the Stock Exchange of Thailand.
The announcement stated that TCPCL Group operates the business of formulating, packaging, distributing, and selling non-alcoholic ready-to-drink beverages in 63 out of 77 provinces in Thailand and in Laos, with trademarks owned by the company.$Coca-Cola (KO.US)$The company owns the trademarks.
$CONCORD NE (00182.HK)$In the first four months, the equity power generation was 3,330.69 GWh, down 2.24% year-on-year; the equity power generation in April was 809.84 GWh, down 6.48% year-on-year.
$TOUYUN BIOTECH (01332.HK)$The subsidiary plans to sell 70% of the equity of Weidao International for 13 million yuan.
$ASCLETIS-B (01672.HK)$A report on the early research of the fat-targeting obesity drug candidate ASC47, aimed at weight loss without muscle loss, will be presented in both oral and poster format at the 32nd European Congress on Obesity (ECO 2025).
$GRAND PHARMA (00512.HK)$The Global innovative product STC3141 has successfully reached clinical endpoints in the Phase II clinical study conducted in China for the treatment of sepsis.
$SDHS NEW ENERGY (01250.HK)$The total operational power generation in the first two months reached approximately 1.0196 million MWh, reflecting a year-on-year increase of about 13.1%.
$EUROEYES (01846.HK)$The total number of ophthalmic surgeries performed in the first quarter was 6,997 cases, a decrease of about 3% year-on-year.
2) Buyback dynamics.
$HSBC HOLDINGS (00005.HK)$A number of non-discretionary repurchase agreements have been signed, aiming to repurchase shares worth up to 3 billion USD.
$COSCO SHIP HOLD (01919.HK)$Invested 42.9239 million HKD to repurchase 3.57 million shares at a repurchase price of 11.78-12.16 HKD.
$SWIRE PACIFIC A (00019.HK)$Invested 23.1486 million HKD to repurchase 0.335 million shares at a repurchase price of 68.35-69.5 HKD.
$SIHUAN PHARM (00460.HK)$Invested HKD 14.684 million to repurchase 20 million shares, with an average repurchase price of HKD 0.7342 per share.
$J&T EXPRESS-W (01519.HK)$Invested HKD 10.0129 million to repurchase 1.63 million shares at a repurchase price of HKD 6.12-6.17.
$DFZQ (03958.HK)$ Plans to invest RMB 0.25 billion-0.5 billion to repurchase A-share stock.
Editor/jayden